A77 1726, the active metabolite of leflunomide, attenuates lupus nephritis by promoting the development of regulatory T cells and inhibiting IL-17-producing double negative T cells
Overview of attention for article published in Clinical Immunology, January 2015
Altmetric Badge
About this Attention Score
-
In the top 25% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (89th percentile)
-
Good Attention Score compared to outputs of the same age and source (78th percentile)
Readers on
- mendeley
- 23 Mendeley